|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.91 CNY | +0.34% |
|
+16.93% | -24.94% |
| Apr. 26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
| Apr. 25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Tibet AIM Pharm. Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 857.98 million compared to CNY 725.46 million a year ago.
Net income was CNY 43.9 million compared to CNY 42.48 million a year ago. Basic earnings per share from continuing operations was CNY 0.23 compared to CNY 0.22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.94% | 235M | |
| +33.29% | 704B | |
| +28.59% | 577B | |
| -3.89% | 348B | |
| +18.35% | 327B | |
| +5.48% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.89% | 147B |
TIBET AIM PHARM. INC. 
